Elacytarabine: lipid vector technology under investigation in acute myeloid leukemia

Author： Keane Niamh   Freeman Ciara   Swords Ronan   Giles Francis J  

Publisher： Informa Healthcare

ISSN： 1747-4086

Source： Expert Review of Hematology, Vol.6, Iss.1, 2013-02, pp. : 9-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis and immaturity in acute myeloid leukemia

By Del Principe Maria Ilaria   Del Poeta Giovanni   Venditti Adriano   Buccisano Francesco   Maurillo Luca   Mazzone Carla   Bruno Antonio   Neri Benedetta   Irno Consalvo Maria   Lo Coco Francesco   Amadori Sergio  

Hematology, Vol. 10, Iss. 1, 2005-02 ,pp. : 25-34

Maney Publishing

Access to resources Recommend Favorite

Serum leptin level in acute myeloid leukemia patients

By Yilmaz M.   Kis C.   Ceylan N. O.   Okan V.   Pehlivan M.   Kuçukosmanoglu E.   Yilmaz F.   Tarakcioglu M.  

Hematology, Vol. 13, Iss. 1, 2008-02 ,pp. : 21-23

Maney Publishing

Access to resources Recommend Favorite

Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia

By Takeshita Akihiro  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 703-716

Springer Publishing Company

Access to resources Recommend Favorite

Is obesity a prognostic factor for acute myeloid leukemia outcome?

By Lee Hun   Licht Andrea   Hyland Andrew   Ford Laurie   Sait Sheila   Block AnneMarie   Barcos Maurice   Baer Maria   Wang Eunice   Wetzler Meir  

Annals of Hematology, Vol. 91, Iss. 3, 2012-03 ,pp. : 359-365

Springer Publishing Company

Access to resources Recommend Favorite

Biology adapted treatment of acute myeloid leukemia

By  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 49-49

Maney Publishing

Access to resources Recommend Favorite